Editas MedicineEDIT

那斯達克 · USD
3.23
+0.15
(+4.87%)
收盤 09/05 03:59 (UTC+8)
盤後 
3.19 
3.19 
(-1.09%)
09/05 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.01
  • 0.01
  • 0.00
  • 0.31
  • 0.05
  • 0.04
  • 0.08
  • 0.25
  • 0.03
  • 0.12
icon
  • -98.11
  • -54.71
  • -88.13
  • 50070.49
  • -84.78
  • -23.19
  • 110.82
  • 228.00
  • -88.56
  • 319.99
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
11,890
2,831
24,741
7,543
3,578
4,658
30,604
61
514
1,135
營業成本
----------
營業毛利
11,890
2,831
24,741
7,543
3,578
4,658
30,604
61
514
1,135
營業費用
30,44427,83432,49632,09155,122-77,197---
研發費用
20,18017,60027,40419,77516,18126,59348,61147,63954,21048,787
推銷及管理費用
11,60310,23411,35312,31612,85913,37516,35418,08818,20619,339
非經常性項目費用
-1,339--6,261-26,08240,85312,232---
其他營業費用
----------
營業利益
-18,554
-25,003
-7,755
-24,548
-51,544
-76,163
-46,593
-65,666
-71,902
-66,991
其他收入及費用
1,3851,0931,6711,8303292,2911,1983,5254,2955,041
利息費用
1,0611,072-4642,3992,0202,216----
稅前純益
-18,230
-24,982
-5,620
-25,117
-53,235
-76,088
-45,395
-62,141
-67,607
-61,950
所得稅
----------
稅後純益
-18,230
-24,982
-5,620
-25,117
-53,235
-76,088
-45,395
-62,141
-67,607
-61,950
基本每股稅後盈餘(元)
-0.15-0.26-0.06-0.28-0.63-0.92-0.55-0.75-0.82-0.76
稀釋每股稅後盈餘(元)
-0.14-0.26--0.26-0.62-0.92-0.55-0.75-0.82-0.76
基本平均股數(千股)
119294.0097879.0097255.0090090.0084412.0083055.0082613.0082485.0082310.0081938.00
稀釋平均股數(千股)
119294.0097879.0097255.0090090.0084412.0083055.0082613.0082485.0082310.0081938.00
還原基本每股稅後盈餘(元)
-0.15-0.26-0.06-0.28-0.63-0.92-0.55-0.75-0.82-0.76
還原稀釋每股稅後盈餘(元)
-0.14-0.26--0.26-0.62-0.92-0.55-0.75-0.82-0.76
還原基本平均股數(千股)
119,29497,87997,25590,09084,41283,05582,61382,48582,31081,938
還原稀釋平均股數(千股)
119,29497,87997,25590,09084,41283,05582,61382,48582,31081,938
EBITDA(千元)
-16,895-23,427-5,279-22,059-49,638-72,538-44,883-61,868-68,067-62,257

大家都在看

HOT